HETERODIMERIC ANTIBODIES THAT BIND CLAUDIN18.2 AND CD3
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Claudin18.2 (CLDN18.2). La présente invention concerne des anticorps, comprenant de nouveaux domaines de liaison à l'antigène et des anticorps hétérodimères, qui se l...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
22.12.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Claudin18.2 (CLDN18.2).
La présente invention concerne des anticorps, comprenant de nouveaux domaines de liaison à l'antigène et des anticorps hétérodimères, qui se lient à la claudine 18.2 (CLDN18.2). |
---|---|
Bibliography: | Application Number: WO2022US33625 |